Key statistics
On Friday, Cytek Biosciences Inc (8EQ:MUN) closed at 6.75, -21.05% below its 52-week high of 8.55, set on Dec 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.75 |
---|---|
High | 6.75 |
Low | 6.75 |
Bid | 6.55 |
Offer | 6.60 |
Previous close | 6.85 |
Average volume | 2.00 |
---|---|
Shares outstanding | 131.51m |
Free float | 122.86m |
P/E (TTM) | -- |
Market cap | 927.11m USD |
EPS (TTM) | -0.0782 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Announcements
- Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
- Cytek Biosciences Announces $50 Million Stock Repurchase Program
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
- Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
- Cytek Biosciences Reports First Quarter 2024 Financial Results
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
More ▼